Key result
Type 2 diabetes is linked to ~0.8 mmHg greater 7-day systolic BP variability versus normal glucose.
Why the study?
The mechanisms associating (pre)diabetes and cardiovascular disease are incompletely understood, with blood pressure variability as a potential underlying factor.
Is type 2 diabetes or prediabetes associated with greater blood pressure variability compared to normal glucose metabolism?
Cross-Sectional (n=3,410)
Is type 2 diabetes or prediabetes associated with greater blood pressure variability compared to normal glucose metabolism?
Mean Difference: 0.76 (95% CI 0.32–1.19)
Type 2 diabetes and prediabetes are associated with slightly greater short- to mid-term blood pressure variability, which may partially explain the increased cardiovascular risk in these populations.
Supports BP variability as contributor to diabetes-related CV risk; leaves open causal role and need for prospective trials.
OBJECTIVE: The mechanisms associating (pre)diabetes and cardiovascular disease (CVD) are incompletely understood. We hypothesize that greater blood pressure variability (BPV) may underlie this association, due to its association with (incident) CVD. Therefore, we investigated the association between (pre)diabetes and very short-term to mid-term BPV, that is within-visit, 24-h and 7-day BPV. METHODS: Cross-sectional data from The Maastricht Study [normal glucose metabolism (NGM), n = 1924; prediabetes, n = 511; type 2 diabetes mellitus (T2DM), n = 975; 51% men, aged 60 ± 8 years]. We determined SD for within-visit BPV (n = 3244), average real variability for 24-h BPV (n = 2699) day (0900-2100 h) and night (0100-0600 h) separately, and SD for 7-day BPV (n = 2259). Differences in BPV as compared with NGM were assessed by multiple linear regressions with adjustment for potential confounders. RESULTS: In T2DM, the average systolic/diastolic values of within-visit, 24-h and 7-day BPV were 4.8/2.6, 10.5/7.3 and 10.4/6.5 mmHg, respectively, and in prediabetes 4.9/2.6, 10.3/7.0 and 9.4/5.9 mmHg, respectively. T2DM was associated with greater nocturnal systolic BPV [0.42 mmHg (95% confidence interval: 0.05-0.80)], and greater 7-day systolic [0.76 mmHg (0.32-1.19)] and diastolic BPV [0.65 mmHg (0.29-1.01)], whereas prediabetes was associated with greater within-visit systolic BPV only [0.35 mmHg (0.06-0.65)], as compared with NGM. CONCLUSION: Both T2DM and prediabetes are associated with slightly greater very short-term to mid-term BPV, which may, according to previous literature, explain a small part of the increased CVD risk seen in (pre)diabetes. Nevertheless, these findings do not detract from the fact that very short-term to mid-term BPV is substantial and important in individuals with and without (pre)diabetes.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2017) conducted a cross-sectional in Type 2 diabetes mellitus and prediabetes (n=3,410). Type 2 diabetes mellitus and prediabetes vs. Normal glucose metabolism was evaluated on Differences in within-visit, 24-h and 7-day blood pressure variability (MD 0.76, 95% CI 0.32-1.19). Type 2 diabetes was associated with greater 7-day systolic blood pressure variability (mean difference 0.76 mmHg; 95% CI 0.32-1.19) compared with normal glucose metabolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: